Mesane kanserli hastalarda HLA sınıf I (A ve B) ve II (DR) allelleri sıklığı
The frequency of HLA class I (A and B) and class II (DR) alleles in patients with bladder cancer
- Tez No: 171641
- Danışmanlar: PROF.DR. BÜLENT ALAGÖL
- Tez Türü: Tıpta Uzmanlık
- Konular: Üroloji, Urology
- Anahtar Kelimeler: Bladder cancers, genetics, HLA 46, Bladder cancers, genetics, HLA 46
- Yıl: 2006
- Dil: Türkçe
- Üniversite: Trakya Üniversitesi
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: Üroloji Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 59
Özet
with primarily bladder cancer HLA B*15 allele and in patients with recurrent bladder cancer HLA DR*13 allele were higher, but not significant statistically.
Özet (Çeviri)
THE FREQUENCY OF HLA CLASS I (A AND B) AND CLASS II (DR) ALLELES IN PATIENTS WITH BLADDER CANCER SUMMARY There are so many etiologic factors performed in the bladder cancer, which is the second most common urologic cancer. In the different races and nations who exposure the similar factors, it has not seen in the same incidence. This difference has evoked the probability of relation with bladder cancers and human leukocyte antigens system that is the genetic identity of races and nations and located in the major histocompatibility complex region of 6th chromosome's short arm. In our study, the frequency of HLA class I (A and B) and class II (DR) alleles of 27 patients with histologically proven urothelial bladder cancer who were living in Trakya region since last three generation was compared with the frequency of HLA class I (A and B) and class II (DR) alleles of 67 healthy volunteers who were also living in Trakya region since last three generation. Typing of HLA was performed by using the low resolution molecular genetic techniques. Statistical analysis was made by using the Chi-square test. In our study, it was determined that HLA A*31, HLA B*15 and HLA B*18 alleles can be facilitative for bladder cancers. There was no protective HLA allele for bladder cancers. In patients with invasive bladder cancer HLA A*1 and HLA DR*4 alleles, in patients with low grade bladder cancer HLA A*26 and HLA B*15 alleles, in patients with high grade bladder cancer HLA A*1 and HLA DR*13 alleles, in patients 45with primarily bladder cancer HLA B*15 allele and in patients with recurrent bladder cancer HLA DR*13 allele were higher, but not significant statistically.
Benzer Tezler
- Mesane kanserli hastalarda intravezikal bacillus calmette-guerin tedavisine yanıtın gen ekspresyon seviyelerindeki farklılıkların incelenmesi
Investigation of differences in gene expression levels in response to intravesical bacillus calmette-guérin therapy in bladder cancer patients
BUĞRA ÇETİN
Doktora
Türkçe
2024
ÜrolojiSağlık Bilimleri ÜniversitesiMoleküler Tıp Ana Bilim Dalı
PROF. DR. YUSUF TUTAR
- Mesane kanserli hastalarda uzun kodlamayan rna-pvtı ve mir-l28 ekspresyonlarının incelenmesi
Long non-coding rna-pvti and mir-l28 in bladder cancer conditionsexamination of expressions
TAGHI AHMADI RENDI
Doktora
Türkçe
2024
Biyokimyaİstanbul ÜniversitesiTıbbi Biyokimya Ana Bilim Dalı
PROF. DR. SEMRA ABBASOĞLU
- Mesane kanserli hastalarda fibrin ile ilişkili yeni bir biyobelirteç olan serum dr-70 düzeyinin prognostik ve prediktif değeri
Prognostic and predictic value of serum DR-70 level, a new fibrin-related biomarker, in patients with bladder cancer
MUSAB ÜMEYİR KARAKANLI
Tıpta Uzmanlık
Türkçe
2024
ÜrolojiSağlık Bilimleri ÜniversitesiÜroloji Ana Bilim Dalı
DOÇ. DR. LEVENT ÖZCAN
DOÇ. DR. MURAT DURSUN
- Mesane kanserli hastalarda serum hyalüronidaz aktivitesi
Serum hyaluronidase activity in patients with bladdercancer
TUBA ÖZGÜN
Tıpta Uzmanlık
Türkçe
2018
BiyokimyaSağlık Bilimleri ÜniversitesiTıbbi Biyokimya Ana Bilim Dalı
UZMAN ELMAS ÖĞÜŞ
- Mesane kanserli hastalarda Metil guanin DNA metil transferaz aktivitesi, glutatyon S transferaz ve nitrik oksit'in önemi
Methyl guanine DNA methyl transferase(MGMT) activities, Glutathione S transferases (GST) and Nitric Oxide (NO) in bladder cancer patients
EYÜP İLKER SAYGILI